Santos, JR, Domingo, P, Portilla, J, Gutiérrez, F, Imaz, A, Vilchez, H, Curran, A, Valcarce-Pardeiro, N, Payeras, A, Bernal, E, Montero-Alonso, M, Yzusqui, M, Clotet, B, Videla, S, Moltó, J, Paredes, R. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 2023; 10(11)DOI:10.1093/ofid/ofad542. PMID:38023553. IF:3.800(Q2/3D).

Nadal E., Oré-Arce M., Remon J., Bernabé-Caro R., Covela-Rúa M., de Castro-Carpeño J., Massutí-Sureda B., Guillot-Morales M., Majem M., Maestu-Maiques I., Morilla-Ruíz I., Gironés R.. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer. Clinical & Translational Oncology. 2023; 25(11)DOI:10.1007/s12094-023-03286-3. PMID:37566345. IF:2.800(Q2/5D).

Serna, N, López-Laguna, H, Aceituno, P, Rojas-Peña, M, Parladé, E, Voltà-Durán, E, Martínez-Torró, C, Sánchez, JM, Di Somma, A, Carratalá, JV, Livieri, AL, Ferrer-Miralles, N, Vázquez, E, Unzueta, U, Roher, N, Villaverde, A. Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation. Pharmaceutics. 2023; 15(11)DOI:10.3390/pharmaceutics15112632. PMID:38004610. IF:4.900(Q1/2D).

León X., Llansana A., Pérez-Ugarte L., García J., Valero C., Quer M., Camacho M.. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.03.003. PMID:37931687. IF:(Q/D).

Pujol A., Llansana A., Pérez-Ugarte L., Sauter B., Quer M., León X.. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2022.10.005. PMID:. IF:(Q/D).

León, X, Bague, S, Holgado, A, Quer, M, Terra, X, Camacho, M, Aviltes-Jurado, FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.05.001. PMID:. IF:(Q/D).

Puig L. [[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.09.020. PMID:37778620. IF:(Q/D).

Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).

Goossens, J, González, AC, Dewit, N, Lidón, L, Fortea, J, Alcolea, D, Lleó, A, Belbin, O, Vanmechelen, E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:8.000(Q1/1D).

Mateos-Dávila, A, Roig, AJB, Rodríguez, JAS, Guix-Comellas, EM. Comparison of diluted vs concentrated regional citrate anticoagulation in continuous renal replacement therapy: A quasi-experimental study. Nursing in Critical Care. 2023; DOI:10.1111/nicc.12991. PMID:37897131. IF:3.000(Q1/1D).

Hueso, M, Rotllan, N, Escolà-Gil, JC, Vellido, A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:2.800(Q2/4D).

Arguello-Tomas, M, Albiol, N, Moreno, C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; 147(1)DOI:10.1159/000534730. PMID:37899041. IF:1.700(Q3/8D).

Kwatra, SG, Yosipovitch, G, Legat, FJ, Reich, A, Paul, C, Simon, D, Naldi, L, Lynde, C, De Bruin-Weller, MS, Nahm, WK, Sauder, M, Gharib, R, Barbarot, S, Szepietowski, JC, Conrad, C, Fleischer, A, Laquer, VT, Misery, L, Serra-Baldrich, E, Lapeere, H, Ahmad, F, Lopez, ZKJ, Piketty, C, Ständer, S. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(17)DOI:10.1056/NEJMoa2301333. PMID:37888917. IF:96.300(Q1/1D).

Broers, MC, Wieske, L, Erdag, E, Gürlek, C, Bunschoten, C, van Doorn, PA, Eftimov, F, Kuitwaard, K, de Vries, JM, de Wit, MCY, Nagtzaam, MMP, Franken, SC, Zhu, LIS, Paunovic, M, de Wit, M, Schreurs, MWJ, Lleixà, C, Martín-Aguilar, L, Pascual-Goñi, E, Querol, L, Jacobs, BC, Huizinga, R, Titulaer, MJ. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023; 95(1)DOI:10.1136/jnnp-2023-331378. PMID:37879898. IF:8.800(Q1/1D).

Escobar, C, Freire, RB, Marimón, XGM, González-Juanatey, C, Morillas, M, Muñoz, AV, Doblas, JJG. A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study. Cardiovascular Diagnosis and Therapy. 2023; 13(5)DOI:10.21037/cdt-23-76. PMID:37941839. IF:2.000(Q3/6D).

Juanola, A, Ma, AT, de Wit, K, Gananandan, K, Roux, O, Zaccherini, G, Jiménez, C, Tonon, M, Solé, C, Villaseca, C, Uschner, FE, Graupera, I, Pose, E, Moreta, MJ, Campion, D, Beuers, U, Mookerjee, RP, Francoz, C, Durand, F, Vargas, V, Piano, S, Alonso, S, Trebicka, J, Laleman, W, Asrani, SK, Soriano, G, Alessandria, C, Serra-Burriel, M, Morales-Ruiz, M, Torres, F, Allegretti, AS, Krag, A, Caraceni, P, Watson, H, Abraldes, JG, Sola, E, Kamath, PS, Hernaez, R, Ginès, P, LiverHope Investigators. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. GUT. 2023; DOI:10.1136/gutjnl-2023-329923. PMID:37884354. IF:23.100(Q1/1D).

Valero-Martínez, C, Urgelles, JF, Sallés, M, Joven-Ibáñez, BE, de Juanes, A, Ramírez, J, Juanola, X, Almodóvar, R, Laiz, A, Moreno, M, Pujol, M, Beltrán, E, Pinto-Tasende, JA, Crespí, L, Sala-Icardo, L, Castañeda, S, García-Vicuña, R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5.700(Q1/3D).

Miró Ò., Osorio G., Alquézar-Arbé A., Aguiló S., Fernández C., Burillo G., Jacob J., Llorens P., Llauger L., Peláez González Á., Figuera Castro E.R., Juarez González R., Blanco Hoffman M.J., Fernandez Salgado F., Pablos Pizarro T., Berenguer Díez M.A., Truyol Más M., López-Laguna N., Garcia Acosta J., Fernandez Domato C., Diego Robledo F.J., Ezponda P., Martinez Lorenzo A., Ortega Liarte J.V., García Rupérez I., Borne Jerez S., Corugedo Ovies C., Gallardo Sánchez B.A., Del Castillo J.G.. Hyperactive delirium during emergency department stay: analysis of risk factors and association with short-term outcomes. Internal and Emergency Medicine. 2023; 19(2)DOI:10.1007/s11739-023-03440-3. PMID:37865623. IF:3.200(Q1/2D).

Socié G., Barba P., Barlev A., Sanz J., García-Cadenas I., Chevallier P., Fagioli F., Guzman-Becerra N., Kumar D., Ljungman P., Pigneux A., Sadetsky N., Yáñez San Segundo L., Shadman M., Storek J., Thirumalai D., Xing B., Mohty M.. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; 59(1)DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4.500(Q1/2D).

Meca-Lallana J.E., Prieto González J.M., Caminero Rodríguez A.B., Olascoaga Urtaza J., Alonso A.M., Durán Ferreras E., Espinosa R., Dotor J., Romera M., Ares Luque A., Pérez Ruiz D., Calles C., Hernández M.A., Hervás García M., Mendoza Rodríguez A., Berdei Montero Y., Téllez N., Herrera Varó N., Sotoca J., Presas-Rodríguez S., Querol Gutierrez L.A., Hervás Pujol M., Batlle Nadal J., Martín Ozaeta G., Gubieras Lillo L., Martínez Yélamos S., Ramió-Torrentà L., Mallada Frechin J., Belenguer Benavides A., Gascón-Giménez F., Casanova B., Landete Pascual L., Berenguer L., Navarro L., Gómez Gutierrez M., Durán C., Rodríguez Regal A., Álvarez E., García-Estévez D.A., López Real A.M., Llaneza González M.A., Marzo Sola M.E., Sánchez-Menoyo J.L., Oterino A., Villaverde González R., Castillo-Triviño T., Álvarez de Arcaya A., Llarena C.. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and Therapy. 2023; 12(6)DOI:10.1007/s40120-023-00557-7. PMID:37861931. IF:4.000(Q1/2D).